INTRODUCTION
============

Sepsis is a global health priority, as recently stated by the World Health Organization.^([@r1],[@r2])^ Current extrapolation based on a recent systematic review estimates 31.5 million cases of sepsis per year worldwide, with a potential of 5.3 million deaths. However, this extrapolation was based on data from high-income countries.^([@r3])^ Since more than 80% of the world\'s population lives in low- and middle-income countries (LMICs), where resource limitations are frequent, the lethality rates are likely much higher.^([@r1],[@r4],[@r5])^ The lack of reliable data on resource availability from LMICs is also noteworthy.^([@r6])^ Although some information is available,^([@r7]-[@r10])^ these studies are largely single-center descriptions or questionnaire-based surveys without random sampling, which might induce selection bias.

Brazil is a middle-income country according to the World Bank^([@r11])^ with an estimated population of approximately 209 million people;^([@r12])^ some data suggest an increase in sepsis-related deaths from 2002 to 2010 in Brazil.^([@r13])^ The Sepsis PREvalence Assessment Database study (SPREAD), a nationwide 1-day point prevalence survey of Brazilian intensive care units (ICU), observed an ICU sepsis incidence of 36.3 cases per 1000 patient-days and an alarming hospital mortality of 55.7%. Low resource availability was independently associated with mortality (odds ratio 1.67, p = 0.045).^([@r14])^ Since this survey generated a nationally representative random sample from Brazilian ICUs with a description of institution infrastructure, resource availability, and ICU organizational aspects from participating units, this information is more representative than previous small convenience cohorts.^([@r15],[@r16])^

Thus, we performed a post hoc analysis of the SPREAD database to characterize and compare the resource availability of participating units. Patient characterization and outcomes were described in the original publication.^([@r14])^

METHODS
=======

The SPREAD study was conducted as a 1-day, prospective, point prevalence study to assess the epidemiology of sepsis in adult ICUs in Brazil.^([@r14])^ A stratified random sample of all Brazilian adult ICUs was generated from the *Associação de Medicina Intensiva Brasileira* (AMIB) 2010 Census.^([@r17])^ It comprised 2,623 ICUs with 28,849 beds. After excluding neonatal and pediatric ICUs, cardiac care units, and burn units, a list of 1,690 ICUs and 19,316 eligible beds remained.

Our sampling method is explained in the original publication.^([@r14])^ Briefly, we created similarly sized strata, each composed of 100 - 500 ICU beds to enhance the representativeness of our random selection of ICUs. Based on the AMIB list, we produced a sampling frame initially stratified by geographic region and size of the cities (considering the location, whether in capital cities or the countryside). Each stratum was then stratified by the hospitals\' main source of income (serving public or privately insured individuals) and ICU size (ten or fewer beds *versus* more than ten beds), finally generating 40 strata. We applied the \"randomize\" (RAND) function in Excel 2010, which generates random numbers for ICUs within each stratum and sequentially contacted their medical directors by telephone and email, inviting them to participate in the study. This study was approved by the research ethics committee at the coordinating center (*Universidade Federal de São Paulo*, Brazil) under the number CAAE: 04719512.0.1001.5505. Informed consent was waived because of the observational nature of the study.

Participants and survey instrument
----------------------------------

We assessed the ICU organizational factors and institution resource availability through a self-reported, questionnaire-based web survey (Supplementary material). The medical director of each ICU answered the questionnaire before study entry and patient data collection. No financial incentive to complete the survey or to participate in the SPREAD study was offered.

The questionnaire was designed by the Steering Committee of the SPREAD study and contained 97 items, which were grouped into eight main categories (general information, hospital facilities, use of clinical protocols and availability of drugs, monitoring tools, laboratory exams, equipment and disposables). The \"general information\" section had two open-ended responses (\'number of hospital beds\' and \'number of ICU beds\' in the institution), which were later categorized by the study investigators. The responses were classified as \'yes\', \'no\' and \'I don\'t know\' for the \"hospital facilities\" section; \'yes, a managed protocol\', \'yes, but not managed\', \'no\' and \'I don\'t know\' for the \"clinical protocols\" section; and \'always\', \'most of the time\', \'in the minority of times\', \'never\', and \'I don\'t know\' for the other sections. No missing variables were allowed. To assess the most relevant resources, the Steering Committee selected eight items using an informal Delphi process before performing any analyses, under the premise that they would be required to comply with the Surviving Sepsis Campaign 6-h bundle.^([@r18])^ These eight items were: blood gas analysis within 3 hours; lactate results within 3 hours; blood, urine and tracheal aspirate (quantitative or qualitative) cultures; antibiotics both for gram-negative (a third-generation cephalosporin plus carbapenems or piperacillin/tazobactam) and gram-positive coverage (vancomycin, teicoplanin or linezolid); crystalloids; noradrenaline; central venous catheter (single or double lumen); and availability for central venous pressure measurement.

Study variables and data analysis
---------------------------------

Since previous literature^([@r19])^ and data from the SPREAD^([@r14])^ study suggested that compliance with the 6-h bundle was associated with lower hospital mortality, we categorized the units according to the availability of all eight items (\'high resource availability\' when all 8 items were always available and \'without high resource availability\' when one or more of the 8 items were not always available). For the analysis, we considered the units as having the resource available only when the answer was \'always\'.^([@r7])^ We also compared the microbiology analysis resource availability and the possibility to administer broad-spectrum antibiotics (defined as antibiotics for both gram-negative and gram-positive coverage as defined in the 8-item section). The possibility to adhere to the Surviving Sepsis Campaign recommendations labeled as \'strong\' and the recent 1-h bundle were evaluated.^([@r20])^

Continuous data are presented as the median (25^th^ - 75^th^ percentile) and were compared using the Mann-Whitney U test. Categorical variables are presented as counts and rates or percentages and were compared with the chi-squared test. P-values \< 0.05 were considered statistically significant. The software Statistical Package for Social Science (SPSS), version 20 (SPSS Inc., Chicago, IL, USA) was used for the statistical analysis.

RESULTS
=======

Of the 368 contacted ICUs, 317 were eligible and 13 (4%) refused to participate. Of the 317 eligible units, 277 (87%) answered the resources survey and are further described in the present publication. Most of the hospitals were small- to medium-sized (262 hospitals, 94.6%) with a median of 14 (9 - 30) ICU beds. In two-thirds of hospitals, the main source of income was the care for public-insured patients (169 ICUs, 61%). The geographic distribution of participating institutions paralleled the Brazilian population distribution among regions. The nurse/patient ratio was 0.13 (0.10 - 0.19), and the nurse technician/patient ratio was 0.5 (0.5 - 0.5). Although most hospitals had emergency departments (247 hospitals, 89.5%) and operating rooms (274 hospitals, 98.9%), only 73.2% had their own microbiology laboratory, and almost half lacked their own blood bank ([Table 1](#t1){ref-type="table"}). Twenty-nine units (10.5%) did not always have the possibility to administer broad-spectrum antibiotics, nine (3.2%) did not always have access to crystalloids and five (1.8%) did not always have vasopressors available (neither norepinephrine nor dopamine) ([Table 2](#t2){ref-type="table"}). In twenty-nine institutions (10.5%), access to blood cultures was not always possible, and 59 (21.3%) could not always measure lactate levels within three hours ([Table 3](#t3){ref-type="table"}).

###### 

General institution characteristics

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variable                              Global\              High resource availability\   Without high resource availability\   p value[\*](#TFN13){ref-type="table-fn"}
                                        (n = 277)            (n = 158)                     (n = 119)                             
  ------------------------------------- -------------------- ----------------------------- ------------------------------------- ------------------------------------------
  Hospital size                                                                                                                  0.669

      ≤ 100 beds                        77 (27.8)            41 (25.9)                     36 (30.3)                              

      101 to 500 beds                   185 (66.8)           109 (69.0)                    76 (63.9)                              

      \> 500 beds                       15 (5.4)             8 (5.1)                       7 (5.9)                                

  ICU beds                                                                                                                       \< 0.001

      ≤ 10                              115 (41.5)           48 (30.4)                     67 (56.3)                              

      11 to 50                          130 (46.9)           89 (56.3)                     41 (34.5)                              

      \> 50                             32 (11.6)            21 (13.3)                     11 (9.2)                               

      ICU beds (number)                 14 (9 - 30)          19 (10 - 35.25)               10 (8 - 20)                           \< 0.001

  Hospital location                                                                                                              \< 0.001

      Capitals                          140 (50.5)           100 (63.3)                    40 (33.6)                              

      Countryside                       137 (49.5)           58 (36.7)                     79 (66.4)                              

  Hospital characteristics                                                                                                       \< 0.001

      Private health system             108 (39.0)           83 (52.5)                     25 (21.0)                              

      SUS                               169 (61.0)           75 (47.5)                     94 (79.0)                              

  Geographic region                                                                                                              0.095

      Southeast                         138 (49.8)           86 (54.4)                     52 (43.7)                              

      South                             46 (16.6)            24 (15.2)                     22 (18.5)                              

      Middle-West                       19 (6.9)             14 (8.9)                      5 (4.2)                                

      Northeast                         53 (19.1)            24 (15.2)                     29 (24.4)                              

      North                             21 (7.6)             10 (6.3)                      11 (9.2)                               

  Teaching status                                                                                                                0.051

      University                        57 (20.6)            26 (16.5)                     31 (26.1)                              

      Non-university                    220 (79.4)           132 (83.5)                    88 (73.9)                              

  Healthcare staff                                                                                                                

      Nurse/patient ratio               0.13 (0.10 - 0.19)   0.13 (0.10 - 0.20)            0.14 (0.10 - 0.18)                    0.510

      Nurse technician/patient ratio    0.5 (0.5 - 0.5)      0.5 (0.5 - 0.5)               0.5 (0.5 - 0.5)                       0.004

      Physician/patient ratio (day)     0.13 (0.10 - 0.17)   0.13 (0.10 - 0.17)            0.13 (0.10 - 0.16)                    0.852

      Physician/patient ratio (night)   0.11 (0.10 - 0.14)   0.10 (0.10 - 0.13)            0.11 (0.10 - 0.14)                    0.043

  Hospital facilities                                                                                                             

      Emergency                         247 (89.5)           140 (88.6)                    107 (89.9)                            0.842

      Operating theater                 274 (98.9)           157 (99.4)                    117 (98.3)                            0.404

      Own blood bank                    162 (59.1)           89 (56.3)                     73 (61.3)                             0.342

      Own laboratory                    232 (83.8)           136 (86.1)                    96 (80.7)                             0.227

      Own microbiology                  202 (73.2)           125 (79.1)                    77 (64.7)                             0.010
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------

ICU - intensive care unit; SUS - Brazilian public health system.

Chi-square or Mann-Whitney U tests between institutions with high resource availability compared to those without. The results are expressed as numbers (%) or the median (25%-75% percentiles).

###### 

Availability of medicines according to the institution availability of resources

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variable                              Global\      High resource availability\   Without high resource availability\   p value[\*](#TFN14){ref-type="table-fn"}
                                        (n = 277)    (n = 158)                     (n = 119)                             
  ------------------------------------- ------------ ----------------------------- ------------------------------------- ------------------------------------------
  Antibiotics (answer: always)                                                                                            

      3^rd^ generation cephalosporins   263 (94.9)   158 (100.0)                   105 (88.2)                            \< 0.001

      4^th^ generation cephalosporins   249 (89.9)   157 (99.4)                    92 (77.3)                             \< 0.001

      Piperacillin/tazobactam           230 (83.0)   155 (98.1)                    75 (63.0)                             \< 0.001

      Carbapenems                       246 (88.8)   157 (99.4)                    89 (74.8)                             \< 0.001

      Vancomycin                        257 (92.8)   158 (100)                     99 (83.2)                             \< 0.001

      Linezolid                         141 (51.5)   105 (66.5)                    36 (30.3)                             \< 0.001

      Macrolide                         217 (78.9)   140 (88.6)                    77 (64.7)                             \< 0.001

      Echinocandins                     113 (41.4)   96 (60.8)                     17 (14.3)                             \< 0.001

      Tigecycline                       112 (41.3)   91 (57.6)                     21 (17.6)                             \< 0.001

  Other drugs (answer: always)                                                                                            

      Hydrocortisone                    267 (96.4)   157 (99.4)                    110 (92.4)                            0.002

      Crystalloids                      268 (96.8)   158 (100.0)                   110 (92.4)                            \< 0.001

      Albumin                           212 (76.5)   138 (87.3)                    73 (61.3)                             \< 0.001

      Norepinephrine                    272 (98.2)   158 (100.0)                   114 (95.8)                            0.009

      Dopamine                          260 (93.9)   152 (96.2)                    108 (90.8)                            0.062

      Dobutamine                        271 (97.8)   158 (100.0)                   113 (95.0)                            0.004

      Adrenaline                        272 (98.2)   158 (100.0)                   114 (95.8)                            0.009

      Vasopressin                       138 (50.5)   103 (65.2)                    35 (29.4)                             \< 0.001

      Red blood cell within 6 hours     249 (89.9)   149 (94.3)                    100 (84.0)                            0.005
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------

Chi-square test between institutions with high resource availability compared to those without. The results are expressed as numbers (%).

###### 

Availability of laboratory exams according to the institution availability of resources

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variable                                    Global\       High resource availability\   Without high resource availability\   p value[\*](#TFN15){ref-type="table-fn"}
                                              (n = 277)     (n = 158)                     (n = 119)                             
  ------------------------------------------- ------------- ----------------------------- ------------------------------------- ------------------------------------------
  Laboratory (answer: always)                                                                                                    

      Direct microscopy/Gram                  0231 (83.4)   150 (94.9)                    81 (68.1)                             \< 0.001

      Blood culture                           248 (89.5)    158 (100.0)                   90 (75.6)                             \< 0.001

      Respiratory secretions (qualitative)    210 (76.6)    151 (95.6)                    59 (49.6)                             \< 0.001

      Respiratory secretions (quantitative)   196 (71.8)    143 (90.5)                    53 (44.5)                             \< 0.001

          Urine culture                       250 (90.3)    158 (100.0)                   92 (77.3)                             \< 0.001

          Blood gas analysis within 3 hours   254 (91.7)    158 (100.0)                   96 (80.7)                             \< 0.001

      Lactate within 3 hours                  218 (78.7)    158 (100.0)                   50 (60.4)                             \< 0.001

      C-reactive protein                      246 (89.1)    151 (95.6)                    95 (79.8)                             \< 0.001

      Procalcitonin                           38 (14.5)     28 (17.7)                     10 (8.4)                              0.026
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Chi-square test between institutions with high resource availability compared to those without. The results are expressed as numbers (%).

The units with high resource availability were usually larger, located in capitals and cared for patients from the private health system compared to those without high resource availability. They also had a higher number of nurse technicians per patient but a similar number of registered nurses and daily physicians per patient ([Table 1](#t1){ref-type="table"}). Among the units without high resource availability, 24.4% did not have broad-spectrum antibiotics, 4.2% did not have vasopressors and 7.6% did not have crystalloids ([Table 2](#t2){ref-type="table"}). Microbiology laboratory resources, lactate measures, disposables, equipment and monitoring devices availability were systematically different between these two types of units ([Tables 3](#t3){ref-type="table"} and [4](#t4){ref-type="table"}). Protocolized care was also different ([Table 5](#t5){ref-type="table"}). Institutions with lower access to microbiology analyses also had lower access to broad-spectrum antibiotics ([Table 6](#t6){ref-type="table"}).

###### 

Availability of disposables and monitoring/diagnosis devices according to the institution availability of resources

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variable                              Global\       High resource availability\   Without high resource availability\   p value[\*](#TFN17){ref-type="table-fn"}
                                        (n = 277)     (n = 158)                     (n = 119)                             
  ------------------------------------- ------------- ----------------------------- ------------------------------------- ------------------------------------------
  Disposables (answer: always)                                                                                             

      Oxygen mask/nasal probes          271 (97.8)    155 (98.1)                    116 (97.5)                            0.75

      Noninvasive ventilation           241 (87.3)    148 (93.7)                    93 (78.2)                             \< 0.001

      Mechanical ventilator             264 (95.6)    154 (97.5)                    110 (92.4)                            0.05

      Tracheal tube                     277 (100.0)   158 (100.0)                   119 (100.0)                           1.00

      Infusion pump                     273 (98.5)    157 (99.4)                    116 (97.5)                            0.152

      Bedside RRT                       239 (86.5)    151 (95.6)                    88 (73.9)                             \< 0.001

      Urinary catheter                  274 (98.9)    158 (100.0)                   116 (97.5)                            0.045

      Enteral tube feeding              268 (96.7)    157 (99.4)                    111 (93.3)                            0.005

      Peripheral catheters              273 (98.5)    158 (100.0)                   115 (96.6)                            0.020

      Central line catheters            267 (97.4)    151 (95.6)                    95 (79.8)                             \< 0.001

  Monitoring devices (answer: always)                                                                                      

      Automatic blood pressure          267 (96.4)    157 (99.4)                    110 (92.4)                            0.002

      Invasive blood pressure           161 (58.1)    129 (81.6)                    32 (26.9)                             \< 0.001

      CVP                               214 (77.3)    158 (100.0)                   56 (47.1)                             \< 0.001

      Noninvasive cardiac output        61 (22.1)     49 (31.0)                     12 (10.1)                             \< 0.001

      Pulmonary artery catheter         79 (28.6)     67 (42.4)                     12 (10.1)                             \< 0.001

      Continuous SvO~2~                 26 (9.6)      24 (15.2)                     2 (1.7)                               \< 0.001

      Bedside X-ray                     262 (94.5)    156 (98.7)                    106 (89.1)                            \< 0.001

      Bedside ultrasound                142 (51.2)    103 (65.2)                    39 (32.8)                             \< 0.001

      Bedside echocardiography          131 (47.2)    98 (62.0)                     33 (27.7)                             \< 0.001

      Computed tomography               223 (80.5)    142 (89.9)                    81 (68.1)                             \< 0.001
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------

RRT - renal replacement therapy; CVP - central venous pressure; SvO~2~ - central venous oxygen saturation.

Chi-square test between institutions with high resource resources compared to those without. The results are expressed as numbers (%).

###### 

Clinical management according to the institution availability of resources

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variable                                      Global\      High resource availability\   Without high resource availability\   p value[\*](#TFN19){ref-type="table-fn"}
                                                (n = 277)    (n = 158)                     (n = 119)                             
  --------------------------------------------- ------------ ----------------------------- ------------------------------------- ------------------------------------------
  Management (answer: always + almost always)                                                                                     

      Invasive blood pressure in shock          199 (71.8)   134 (84.8)                    65 (54.6)                             \< 0.001

      CVP in shock                              237 (85.6)   143 (90.5)                    94 (79.0)                             0.007

      CVP in hyperlactatemia                    217 (78.3)   141 (89.2)                    106 (63.9)                            \< 0.001

      Fluid responsiveness                      83 (30.3)    65 (41.1)                     18 (15.3)                             \< 0.001

      SvcO~2~ in shock                          231 (83.4)   138 (87.3)                    93 (78.2)                             0.042

      SvcO~2~ in hyperlactatemia                218 (78.7)   137 (86.7)                    81 (68.6)                             \< 0.001

      Lactate in severe sepsis suspicious       247 (89.2)   155 (98.1)                    92 (77.3)                             \< 0.001

  Protocolized care                                                                                                               

      Sepsis                                    228 (82.3)   140 (88.6)                    88 (73.9)                             0.002

      Glycemic control                          255 (92.1)   149 (94.3)                    106 (89.1)                            0.111

      Sedation                                  227 (81.9)   133 (84.2)                    94 (79.0)                             0.267

      MV weaning                                239 (86.3)   139 (88.0)                    100 (84.0)                            0.345

      Nutrition                                 214 (77.8)   134 (84.8)                    80 (68.4)                             0.001
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------

CVP - central venous pressure; SvO~2~ - central venous oxygen saturation; MV - mechanical ventilation.

Chi-square test between institutions with high resource availability compared to those without. The results are expressed as numbers (%).

###### 

Microbiology resources according to antibiotic availability

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variable                                    Has broad-spectrum ATB availability\   Does not have broad-spectrum ATB availability\   p value[\*](#TFN21){ref-type="table-fn"}
                                              (n = 248)                              (n = 29)                                         
  ------------------------------------------- -------------------------------------- ------------------------------------------------ ------------------------------------------
  Laboratory (answer: always)                                                                                                          

      Direct microscopy/Gram                  215 (86.7)                             16 (55.2)                                        \< 0.001

      Blood culture                           231 (93.1)                             17 (58.6)                                        \< 0.001

      Respiratory secretions (qualitative)    196 (79.0)                             14 (48.3)                                        0.001

      Respiratory secretions (quantitative)   185 (74.6)                             11 (37.9)                                        \< 0.001

      Urine culture                           233 (94.0)                             17 (58.6)                                        \< 0.001
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

ATB - antibiotic. Adequate broad-spectrum ATB availability - antibiotics both for gram-negative (a third-generation cephalosporin plus carbapenens or piperacillin/tazobactam) and gram-positive coverage (vancomycin, teicoplanin or linezolid).

Chi-square test between institutions with high resource availability compared to those without. The results are expressed as numbers (%).

Among all units, 214 (77.3%) were able to adhere to the 1-h bundle, and 219 (79.1%) were able to adhere to the \'strong\' recommendations from the Surviving Sepsis Campaign. Notable differences were observed between the units with high resource availability and those without ([Table 7](#t7){ref-type="table"}).

###### 

Possibility to adhere to the 1-hour bundle and to the Surviving Sepsis Campaign 'strong' recommendations

  ------------------------------------------------------------------------------------------------------------------------------------------------------
  Variable                   Global\      High resource availability\   Without high resource availability\   p value[\*](#TFN22){ref-type="table-fn"}
                             (n = 277)    (n = 158)                     (n = 119)                             
  -------------------------- ------------ ----------------------------- ------------------------------------- ------------------------------------------
  1-hour bundle              214 (77.3)   158 (100.0)                   56 (47.1)                             \< 0.001

  'Strong' recommendations   219 (79.1)   139 (88.0)                    80 (67.2)                             \< 0.001
  ------------------------------------------------------------------------------------------------------------------------------------------------------

Chi-square test between institutions with high resource availability compared to those without. The results are expressed as numbers (%).

DISCUSSION
==========

The results of our nationwide, random, self-reported, questionnaire-based survey of a representative sample of Brazilian adult ICUs indicate that a substantial number of units cannot perform some basic monitoring (e.g., lactate measurement) and therapeutic interventions (e.g., broad-spectrum antibiotics) in septic patients. Human resources, medicine, equipment and laboratory availability are systematically different when comparing units with high resource availability (as a surrogate to adhere to the 6-h bundle) and those without. Almost one-quarter of ICUs could not comply with the 1-h bundle because of the lack of resources rather than the short time frame. Our results are relevant both for our country and as a framework to study the availability of resources in LMICs.

Information on resource availability in LMICs is scarce and is mostly limited to single-center data instead of representative national samples.^([@r21])^ In the ICON study, only 8.5% of participating centers were from low-income countries. Notably, a higher in-hospital risk of death was independently associated with a lower national income.^([@r22])^ One of the possible explanations is the difference in equipment, training and resource availability among centers. These differences might affect the possibility to adhere to first-line treatments. In fact, in the SPREAD study, lower resource availability was associated with a higher mortality in the multivariate analysis.^([@r14])^ Conversely, the IMPRESS study suggests that compliance with evidence based-bundles is associated with a lower mortality.^([@r19])^ Since resource availability in critical care seems to be associated with outcomes, the health care inequalities of LMICs, albeit notorious,^([@r23])^ should be further characterized.

Previous publications have suggested that the implementation of sepsis bundles in some LMICs is compromised because the availability of equipment, drugs and disposables are inadequate.^([@r7]-[@r10])^ Baelani et al. reported that in some African countries, 16.3% of units could implement the resuscitation bundles, which is much lower than the percentage in high-income countries (93.2%).^([@r7])^ Although our results for the 1-h bundle were better than those from African units, only 77.3% of our institutions had availability of required resources. When evaluating the individual components of the 1-h bundle in our study, it is particularly striking that some key therapeutic interventions are not always available (e.g., 3.2% lacked crystalloids, 1.8% lacked vasopressors, and 10.5% did not have broad-spectrum antibiotics). The unavailability of antibiotics is particularly worrisome since 60% of observed infections in SPREAD patients were health-care associated infections (which usually occur due to multiresistant microorganisms). We also observed a relationship between microbiology analysis resources and antibiotic availability (i.e., a lack of microbiology tests was associated with a lower availability of antibiotics). Although some institutions cannot perform all microbiology analyses, they should have antibiotics available to avoid treatment delays since the time from infection to antibiotic use is associated with sepsis outcomes.^([@r24])^

We also evaluated ICU staffing in our sample, with encountered values lower than those observed in high-income countries^([@r25])^ and even Mongolian centers.^([@r9])^ Unfortunately, there is a paucity of current ICU staffing data from LMICs and its relationship with outcomes. Previous information has demonstrated the association between both nurse staffing^([@r26])^ and the intensivist-patient ratio^([@r27])^ with hospital mortality and severe burnout,^([@r28])^ but these data are mainly from high-income countries. In Brazil, Tironi et al. observed a burnout prevalence of 61.7% in intensivists and the lack of resources as a stressor during ICU shifts in 47.4% of staff.^([@r29])^ Recently, the ORCHESTRA study failed to demonstrate a significant impact of physician or nurse staffing patterns on hospital mortality in Brazil.^([@r30])^ Although we acknowledge that the ORCHESTRA study was not meant to specifically address septic patients and some differences between participating units in the ORCHESTRA and our study exist (such as the number of participating units from the private health system, geographic distribution alongside Brazilian regions and capitals, the nurse/patient ratio), we also did not identify staffing pattern as a significant factor associated with hospital mortality (Supplementary web appendix and [Table 5](#t5){ref-type="table"} published with the SPREAD study - Lancet Infect Dis. 2017;17(11):1180-9).^([@r14])^

Our study has some strengths. Our sampling was representative of Brazilian institutions with ICUs. Our study design is original and might help explain the dynamics of resource availability in upper middle-income countries and may help plan future studies at the national level. The low rate of refusal to participate also improves our internal and external validity.

This study also has some limitations. First, the survey was self-reported, and we did not perform audits to evaluate whether the responses were accurate. However, the questionnaire was required to be fully completed before the units could participate in the SPREAD study, and the random stratified sampling method increases the validity and representativeness of our results. Second, although the questionnaire was designed by a committee with previous experience in critical care research and ICU organization aspects and reviewed by board-certified intensivists involved with ICU management, no assessment of test-retest reliability was performed. Third, our data might not be applicable to other countries, even LMICs, although the methods might be replicable in other countries to obtain high-quality data.^([@r4])^

CONCLUSION
==========

Our nationwide, randomized survey of a representative sample of Brazilian adult intensive care units indicates that in a substantial number of institutions, there is a lack of required resources to perform basic monitoring and interventions in septic patients. Our results highlight major opportunities for the improvement of effective evidence-based interventions in Brazil. This study may also serve as a framework to evaluate resource availability in low- and middle-income countries.

Supplementary Material
======================

###### 

Click here for additional data file.
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